IRIS

RISITANO, ANTONIO MARIA

RISITANO, ANTONIO MARIA  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 191 (tempo di esecuzione: 0.026 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome 1.1 Articolo in rivista 2002 Risitano, ANTONIO MARIA; Camera, A.; Chiurazzi, F.; Rossi, M.; D'Arco, A. M.; Rotoli, Bruno
Paroxysmal Nocturnal Hemoglobinuria: significant association with specific HLA-A, B, C and DR alleles in Italian patients 1.1 Articolo in rivista 2008 Lombardi, Ml; Terrazzano, G; Cosentini, Elena; Gargiulo, L; Risitano, ANTONIO MARIA; Camerlengo, R; Sica, M; Aufiero, D; Poggi, A; Pirozzi, G; Rotoli, Bruno; Luzzatto, L; Notaro, R; Alfinito, Fiorella; Ruggiero, Giuseppina
Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. 1.1 Articolo in rivista 1999 Montuori, Nunzia; Selleri, Carmine; Risitano, ANTONIO MARIA; Raiola, Am; Ragno, P; DEL VECCHIO, Luigi; Rotoli, Bruno; Rossi, G.
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. 1.1 Articolo in rivista 2007 Hillmen, P; Muus, P; Duhrsen, U; Risitano, ANTONIO MARIA; Schubert, J; Luzzatto, L; Schrezenmeier, H; Szer, J; Brodsky, Ra; Hill, A; Socie, G; Bessler, M; Rollins, Sa; Bell, L; Rother, Rp; Young, N. S.
Significance of oligoclonal and polyclonal expansion within CD8 and CD4 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by VB CDR3 spectratyping and flow cytometry. 1.1 Articolo in rivista 2002 Risitano, ANTONIO MARIA; H., Kook; W., Zeng; G., Chen; Ns, Young; Jp, M. a. c. i. e. j. e. w. s. k. i.
Paroxysmal nocturnal hemoglobinuria and other complement-mediated haematological disorders. Immunobiology. 1.1 Articolo in rivista 2012 Risitano, ANTONIO MARIA
Multi-center experience using total lymphoid irradiation and anti-thymocyte globulin as conditioning for allografting in hematological malignancies. 1.1 Articolo in rivista 2012 Messina, G; Giaccone, L; Festuccia, M; Irrera, G; Scortechini, I; Sorasio, R; Gigli, F; Passera, R; Cavattoni, I; Filippi, Ar; Schianca, Fc; Pini, M; Risitano, ANTONIO MARIA; Selleri, C; Levis, A; Mordini, N; Gallamini, A; Pastano, R; Casini, M; Aglietta, M; Montanari, M; Console, G; Boccadoro, M; Ricardi, U; Bruno, B.
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases. 1.1 Articolo in rivista 2011 Fridkis Hareli, M; Storek, M; Mazsaroff, I; Risitano, ANTONIO MARIA; Lundberg, As; Horvath, Cj; Holers, V. M.
Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. 1.1 Articolo in rivista 2011 Risitano, ANTONIO MARIA; Perna, F; Selleri, C.
Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of life. 1.1 Articolo in rivista 2010 Oliva, En; Nobile, F; Alimena, G; Specchia, G; Danova, M; Rovati, B; Ronco, F; Impera, S; Risitano, ANTONIO MARIA; Alati, C; Breccia, M; Carmosino, I; Vincelli, I; Latagliata, R.
Fas-mediated apoptosis is important in regulating cell replication and death in trysomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. 1.1 Articolo in rivista 2002 Em, Sloand; S., Kim; M., Fuhrer; Risitano, ANTONIO MARIA; R., Nakamura; J., Maciejewski; J., Barrett; Ns, Y. o. u. n. g.
CD34+ cells from Paroxysmal Nocturnal Hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc). 1.1 Articolo in rivista 2003 Risitano, ANTONIO MARIA; K., Holada; G., Chen; J., Simak; Jg, Vostal; Ns, Young; Jp, M. a. c. i. e. j. e. w. s. k. i.
T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy. 1.1 Articolo in rivista 2003 Fogarty, Pf; Rick, Me; Zeng, W; Risitano, ANTONIO MARIA; Dunbar, Ce; Bussel, J.
Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents. 1.1 Articolo in rivista 2008 Risitano, ANTONIO MARIA; Rotoli, B.
PNH and eculizumab. 1.1 Articolo in rivista 2010 Luzzatto, ; Risitano, ANTONIO MARIA; Notaro, R.
Aplastic anemia: immunosuppression. Current challenges and future goals in immunosuppression for aplastic anemia. 1.1 Articolo in rivista 2009 Risitano, ANTONIO MARIA
Supportive care in severe and very severe aplastic anemia. 1.1 Articolo in rivista 2013 Höchsmann, B; Moicean, A; Risitano, ANTONIO MARIA; Ljungman, P; Schrezenmeier, H.
Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens. 1.1 Articolo in rivista 2002 H., Kook; Risitano, ANTONIO MARIA; W., Zeng; M., Wlodarski; C., Lottemann; R., Nakamura; J., Barrett; Ns, Young; Jp, M. a. c. i. e. j. e. w. s. k. i.
Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010 Meeting Report. 1.1 Articolo in rivista 2011 Malcovati, L; de Latour, Rp; Risitano, ANTONIO MARIA
Easy genotyping of complement C3 'slow' and 'fast' allotypes by tetra-primer amplification refractory mutation system PCR. 1.1 Articolo in rivista 2010 Peruzzi, B; Serra, M; Pescucci, C; Sica, M; Lastraioli, S; Rondelli, T; Pedemonte, S; Risitano, ANTONIO MARIA; De Angioletti, M; Piccioli, P; Notaro, R.